Q4 & FY 2025 Q4 2025 Financial Highlights February 6, 2026 Forward-looking Statements and Non-GAAP Measures 2 • These slides may contain forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or imp ...

Q1 FISCAL YEAR 2026 Supplemental Information 1 Revenue Composition(1) | ($ in thousands) | | | | | | | | | | Quarter Ended | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | December 31, 2025 | | September 30, 2025 | | June 30, 2025 | | March 31, 2025 | | December 31, 2024 | | September 30, 2024 | | June 30, 2024 | | March 31, 2024 | | December 31, 2023 | | Software and related service revenue | | | | | | | | | | | | | ...

February 6, 2026 Q4 AND FULL YEAR 2025 FINANCIAL RESULTS AND BUSINESS UPDATE FORWARD-LOOKING STATEMENTS This presentation and discussions during this conference call contain forward-looking statements, relating to: our strategy and plans; potential of, and expectations for, our commercial business and pipeline programs; capital allocation and investment strategy; clinical development programs, clinical trials, and data readouts and presentations; regulatory discussions, submissions, filings, and approvals; ...

Carlyle Reports Fourth Quarter and Full-Year 2025 Financial Results FEBRUARY 6, 2026 Carlyle Reports Fourth Quarter and Full-Year 2025 Financial Results WASHINGTON, DC AND NEW YORK, NY – February 6, 2026 – The Carlyle Group Inc. (NASDAQ: CG) today reported its unaudited results for the fourth quarter and full- year ended December 31, 2025. U.S. GAAP Results For Q4 2025 and FY 2025, U.S GAAP results included income before provision for income taxes of $462 million and $1.2 billion, respectively, and a margin ...

Fourth Quarter 2025 Results February 6, 2026 Non-GAAP financial measures and forward-looking statements Non-GAAP financial measures We provide reconciliations of the non-GAAP financial measures contained in this presentation to the most directly comparable measure under GAAP, which are set forth in the financial tables attached to this presentation. The non-GAAP financial measures in this presentation include: adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA margin"); adjuste ...

Preliminary Financial Results H2 2025 SAFE HARBOR STATEMENT This document, in particular references to "FY 2026 Financial Guidance", contains forward looking statements. In particular, statements regarding future financial performance and the Company's expectations as to the achievement of certain targeted metrics, including revenues, industrial free cash flows, vehicle shipments, capital investments, research and development costs and other expenses at any future date or for any future period are forward-l ...

Financial Results and Business Update for the Quarter Ended December 31, 2025 February 6, 2026 Disclaimer This presentation is intended for the investor community only; it is not intended to promote the product candidates referenced herein or otherwise influence healthcare prescribing decisions. For investor audiences only 2 Forward-Looking Statements This presentation includes forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materi ...

SECOND QUARTER FY 2026 RESULTS FEBRUARY 5, 2026 INTRODUCTION Markus Strobel, Executive Chairman & Interim Chief Executive Officer Laurent Mercier, Chief Financial Officer 2 OVERVIEW JOINING COTY AT A PIVOTAL MOMENT Markus Strobel, Executive Chairman & Interim Chief Executive Officer ABOUT MARKUS STROBEL 4 ➢ 33-year career at Procter & Gamble with strong discipline and operational expertise ➢ 25 years at P&G Beauty, where he most recently served as President of P&G's Global Skin & Personal Care business whic ...

2Q26 | 6M26 RESULTS PRESENTATION André Guillaumon CEO Gustavo Lopez CFO & IRO Ana Paula Zerbinati IR and Capital Market Head 6M26 EARNINGS CALL PORTUGUÊS Essa videoconferência será em português, com tradução simultânea para o inglês. Alteração de Idioma: para acessar a tradução simultânea, clique no botão Interpretation, na parte inferior direita da tela, e escolha o idioma "Inglês". Para fazer perguntas: clique no ícone Q&A e escreva seu nome e empresa ou levante a mão para entrar na fila. Ao ser anunciado ...

Powering and transforming financial markets Investor Presentation February 2026 Forward-Looking Statements This presentation and other written or oral statements made from time to time by representatives of Broadridge Financial Solutions, Inc. ("Broadridge" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical in nature, and which may be identified by the use of words such as "expects," "assumes, ...